Patent Assignment
Reel/Frame 047605/0756
General Conveyance and Assumption Agreement
Recorded: 2018-11-20
Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP,
300, 4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property
(1)
Novel Bicyclic Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 047552/0613 →
Assignment of Assignor's Interest
Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 047605/0785 →
Change of Name
Nov 20, 2018
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 048148/0718 →
Assignment of Assignor's Interest
Nov 20, 2018
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 048148/0736 →